SCHEMBL23263136

SCHEMBL23263136

O=c1c(OCc2ccccc2)ccccc1-c1cscn1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CARM1 Q86X55 2/20 0.42
PRMT1 Q99873 2/20 0.42
BRD4 O60885 4/20 0.42
IDO1 P14902 2/20 0.41
MAPT P10636 1/20 0.41
MAPK1 P28482 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
TNKS2 Q9H2K2 2/20 0.40
LTA4H P09960 1/20 0.40
MAPK14 Q16539 1/20 0.40
SCN9A Q15858 1/20 0.40
ALPG P10696 1/20 0.39
PTK2B Q14289 1/20 0.39
RXRA P19793 1/20 0.39
RXRB P28702 1/20 0.39
RXRG P48443 1/20 0.39
HTR1A P08908 1/20 0.39
DRD2 P14416 1/20 0.39
PTGER1 P34995 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23263872 0.89 L3MBTL1 (0.42) CARM1PRMT1BRD4MAPTL3MBTL1
SCHEMBL23263349 0.86 PTPN1 (0.45) PTGER1
SCHEMBL23263870 0.78 KDM1A (0.38) CARM1PRMT1IDO1SCN9AHTR1A
SCHEMBL27018589 0.78 NPC1 (0.36) CARM1PRMT1BRD4MAPTPTGER1
SCHEMBL23263217 0.78 BRD4 (0.42) BRD4IDO1MAPTMAPK1TDP1
SCHEMBL23263353 0.77 IDO1 (0.46) CARM1PRMT1BRD4IDO1MAPT
SCHEMBL23263347 0.76 ADRA1D (0.51) BRD4IDO1MAPTMAPK1TDP1
SCHEMBL27018580 0.76 NPC1 (0.39) BRD4MAPTPTGER1
SCHEMBL23263948 0.75 IDO1 (0.44) BRD4IDO1MAPTMAPK1TDP1
SCHEMBL23263138 0.75 BRD4 (0.43) BRD4IDO1MAPTMAPK1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240018105-A1 TROPOLONE DERIVATIVES AND TAUTOMERS THEREOF FOR IRON REGULATION IN ANIMALS KINESID THERAPEUTICS, INC. (US) 2024-01-18 US disclosed
US-20240018105-A1 TROPOLONE DERIVATIVES AND TAUTOMERS THEREOF FOR IRON REGULATION IN ANIMALS KINESID THERAPEUTICS, INC. (US) 2024-01-18 US disclosed
WO-2021076945-A1 TROPOLONE DERIVATIVES AND TAUTOMERS THEREOF FOR IRON REGULATION IN ANIMALS Ambys Medicines, Inc. (US) 2021-04-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240018105-A1 TROPOLONE DERIVATIVES AND TAUTOMERS THEREOF FOR IRON REGULATION IN ANIMALS TXNRD2, TXNRD1, SDHB CARM1 3538/4885PRMT1 2138/4885BRD4 4625/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.